Search Results 41-50 of 8336 for TNF

  1. Postoperative Infections Clinical Trials

    ... Tumor Necrosis Factor (anti-TNF) agents infliximab, adalimumab, and certolizumab. However, many CD and UC patients still ultimately require surgery despite ...

  2. A Study to Establish An Integrated Biomarker Panel for COVID-19 Infection Risk and Severity Prediction - Mayo Clinic

    Hypothesis: Baseline cytokine (IL-1β, IL-6, IL-4, IL-10, IFN-g and TNF-a) and the immune cellular repertoire (helper/CD4+, cytotoxic/CD8+, T-regulatory ...

  3. Jin-San Zhang, Ph.D. - Mayo Clinic Faculty Profiles

    The NF-kappa B activation is also responsible for tumor necrosis factor-alpha (TNF-alpha) and tumor necrosis factor (TNF)-related apoptosis-inducing ligand ( ...

  4. Inflammatory bowel disease biobank research update - Mayo Clinic

    ... tumor necrosis factor (TNF) therapy. They examined how a patient's genetic risk burden or profile affects the disease course and individual responses to ...

  5. Crohn's Disease Clinical Trials

    ... tumor necrosis factor (TNF-IR). Participants who enroll on the basis of refractory or intolerance to CS and/or IS may have been previously exposed to anti ...

  6. Inflammatory Bowel Disease Clinical Trials

    ... Tumor Necrosis Factor (TNF) therapy. A Study of Measurable Ultrasound Imaging Biomarkers of Crohn's Disease Rochester, MN. The purpose of this study is to ...

  7. Head-to-head comparison between vedolizumab and adalimumab for treatment of moderately to severely active ulcerative colitis - Mayo Clinic

    The Food and Drug Administration approved the use of anti-tumor necrosis factor and anti-integrin agents for the treatment of ulcerative colitis in 2005 ...

  8. Mayo Clinic Researchers Find New Molecule to Target in Pancreatic Cancer Treatment

    The research team discovered that increased activity of the alternative NF-kB pathway results from suppression of TNF receptor-associated factor 2, or TRAF2.

  9. Publications - Brett A. Koplin, M.D. - Mayo Clinic

    Cachectin/tumor necrosis factor-secreting tumor in skeletal muscle induces chronic cachexia, while implantation in brain induces predominantly acute anorexia. J ...

  10. AMG 181 Phase 2 Study in Subjects with Moderate to Severe Ulcerative Colitis - Mayo Clinic

    Anti-TNF agents; Corticosteroids (non-US sites only). Neurological exam free of clinically significant, unexplained signs or symptoms during screening and no ...